Role of financial toxicity in perpetuating health disparities

Ramsey, 2016, Financial insolvency as a risk factor for early mortality among patients with cancer, J. Clin. Oncol., 34, 980, 10.1200/JCO.2015.64.6620 Gordon, 2017, A systematic review of financial toxicity among cancer survivors: we can't pay the co-pay, Patient, 10, 295, 10.1007/s40271-016-0204-x Panzone, 2021, Association of race with cancer-related financial toxicity, JCO Oncol. Pract., 18, e271, 10.1200/OP.21.00440 Chan, 2019, Relationships between financial toxicity and symptom burden in cancer survivors: a systematic review, J. Pain Symptom Manag., 57, 646, 10.1016/j.jpainsymman.2018.12.003 Chino, 2017, Out-of-pocket costs, financial distress, and underinsurance in cancer care, JAMA Oncol., 3, 1582, 10.1001/jamaoncol.2017.2148 Bestvina, 2014, Patient-oncologist cost communication, financial distress, and medication adherence, JCO Oncol. Pract., 10, 162, 10.1200/JOP.2014.001406 Bradley, 2021, Time to add screening for financial hardship as a quality measure?, CA Cancer J. Clin., 71, 100, 10.3322/caac.21653 Chino, 2019, Financial toxicity and equitable access to clinical trials, Am. Soc. Clin. Oncol. Educ. Book, 39, 11, 10.1200/EDBK_100019 Gupta, 2021, Financial burden of drugs prescribed for cancer-associated symptoms, JCO Oncol. Pract., 18, 140, 10.1200/OP.21.00466 Nipp, 2019, Addressing the financial burden of cancer clinical trial participation: longitudinal effects of an equity intervention, Oncologist, 24, 1048, 10.1634/theoncologist.2019-0146 Essien, 2021, A policy prescription for reducing health disparities-achieving pharmacoequity, JAMA, 326, 1793, 10.1001/jama.2021.17764 Sloan, 2018, Ask early and ask often: how discussing costs could save your patient's life, N. C. Med. J., 79, 39 Lee, 2020, Assessment of parking fees at national cancer institute-designated cancer treatment centers, JAMA Oncol., 6, 1295, 10.1001/jamaoncol.2020.1475 Abt Associates, 2020 Tarnasky, 2021, Mobile application to identify cancer treatment–related financial assistance: results of a randomized controlled trial, JCO Oncol. Pract., 17, e1440, 10.1200/OP.20.00757